Nano-hydrogel-based delivery system for dihydroartemisinin to enhance cuproptosis and synergize with anti-PD-1 therapy in triple-negative breast cancer
Qiaoli Yi, Fada Xia, Tong‐Fei Li, Jiayu Wang et autres
As an aggressive subtype of breast cancer, triple-negative breast cancer (TNBC) displays limited therapeutic options and poor clinical prognosis. Thus, there is an urgent need for developing more effective treatment strategies to optimize the clinical management of TNBC. Dihydroartemisinin (DHA), one kind …
cn (code pays fourni par la source)
0 citations
Journal of Nanobiotechnology